Lemon balm
Melissa officinalis evidence comes from a small, heterogeneous group of preparations and populations. Extract details and outcome definitions must remain visible.
No FDA Daily Value, RDA, AI or UL
Study exposures are not a daily requirement or evidence that a proprietary blend matches them.
Compare nutrient-reference terminology →What the research can—and cannot—support
A meta-analysis reported signals for anxiety and depressive-symptom scores across a small group of trials.
High heterogeneity, few studies and differing methods limit firm conclusions.
The evidence does not establish treatment of anxiety or depression by a multi-ingredient supplement.
Fields to verify on a real product
A familiar ingredient name is not enough to match a study or judge transparency.
Melissa officinalis leaf identity
Powder, tea or extract
Extract ratio and marker standardization
Individual amount per serving
Important reasons to pause
General information only. Suitability depends on the exact product, amount, health context and medication list.
- Special-population and long-term data are limited.
- Medication and sedating-ingredient combinations need review.
- Disease-oriented mental-health claims require a much higher evidence and regulatory standard.
Where this ingredient appears in reviewed formulas
A label appearance does not transfer this ingredient evidence to the finished product. No affiliate link appears in this section.
Primary and evidence-synthesis sources
- Ghazizadeh et al., 2021Systematic review/meta-analysis with substantial heterogeneity and few trials.